1. Home
  2. OCUL vs EXPI Comparison

OCUL vs EXPI Comparison

Compare OCUL & EXPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • EXPI
  • Stock Information
  • Founded
  • OCUL 2006
  • EXPI 2008
  • Country
  • OCUL United States
  • EXPI United States
  • Employees
  • OCUL N/A
  • EXPI N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • EXPI Real Estate
  • Sector
  • OCUL Health Care
  • EXPI Finance
  • Exchange
  • OCUL Nasdaq
  • EXPI Nasdaq
  • Market Cap
  • OCUL 1.8B
  • EXPI 1.6B
  • IPO Year
  • OCUL 2014
  • EXPI N/A
  • Fundamental
  • Price
  • OCUL $13.60
  • EXPI $11.22
  • Analyst Decision
  • OCUL Strong Buy
  • EXPI Strong Buy
  • Analyst Count
  • OCUL 6
  • EXPI 1
  • Target Price
  • OCUL $17.20
  • EXPI $12.00
  • AVG Volume (30 Days)
  • OCUL 2.2M
  • EXPI 953.1K
  • Earning Date
  • OCUL 08-05-2025
  • EXPI 07-31-2025
  • Dividend Yield
  • OCUL N/A
  • EXPI 1.78%
  • EPS Growth
  • OCUL N/A
  • EXPI N/A
  • EPS
  • OCUL N/A
  • EXPI N/A
  • Revenue
  • OCUL $56,664,000.00
  • EXPI $4,593,157,000.00
  • Revenue This Year
  • OCUL N/A
  • EXPI $3.60
  • Revenue Next Year
  • OCUL $18.87
  • EXPI $4.71
  • P/E Ratio
  • OCUL N/A
  • EXPI N/A
  • Revenue Growth
  • OCUL N/A
  • EXPI 3.62
  • 52 Week Low
  • OCUL $5.79
  • EXPI $6.90
  • 52 Week High
  • OCUL $13.82
  • EXPI $15.39
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 68.16
  • EXPI 61.63
  • Support Level
  • OCUL $12.41
  • EXPI $10.46
  • Resistance Level
  • OCUL $12.49
  • EXPI $11.24
  • Average True Range (ATR)
  • OCUL 0.56
  • EXPI 0.37
  • MACD
  • OCUL 0.04
  • EXPI 0.04
  • Stochastic Oscillator
  • OCUL 88.48
  • EXPI 76.32

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About EXPI eXp World Holdings Inc.

eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services. The company mainly operates in the United States and Canada, and it also has operations in the United Kingdom, Australia, South Africa, France, India, Portugal, and Mexico, among others.

Share on Social Networks: